Breast Cancer in Young Women: Signs, Risks, and Latest Research

Rising incidence rates, unique challenges, and more stats and facts to know about how breast cancer impacts younger women

It’s a long-standing myth that breast cancer only affects older women. And it’s not hard to see why: The median age at the time of breast cancer diagnosis is 63, and a very small number of women are diagnosed at a younger age—though the number of women being diagnosed under 50 is growing.

But breast cancer can affect women at any age, and knowing the warning signs matters especially for younger women, who are far less likely to be routinely screened. In fact, nearly 80% of younger women who are diagnosed find their own abnormality, making self-awareness one of the most important tools available.

Why Breast Cancer in Young Women Is on the Rise

To the alarm of experts, the breast cancer incidence rate in women under 50 has risen faster (about 1.4% each year between 2012 and 2022) than in women over 50 (about 0.7% each year). While breast cancer incidence in younger women is still low, at about 52 per 100,000 in 2023, it is a deeply concerning trend. Some estimates suggest women under 40 are nearly 40% more likely to die from their breast cancer than women over 40. Breast cancer is currently the leading cause of cancer death in women aged 20 to 49 in the U.S.

The American Cancer Society reported that women under 50 now have an 82% higher cancer incidence rate than men of the same age, a trend primarily driven by increasing rates of breast cancer.

Researchers say the reasons for the rising incidence in younger women are complex, multifactorial, and not yet fully understood. Contributing factors under investigation include changing childbearing and breastfeeding patterns, increased alcohol use, excess body fat, genetics, environmental exposures, and more. Understanding what is driving the rise remains an active area of research.

Breast Cancer Research Foundation (BCRF) investigators and other scientists around the world have long been focused on understanding breast cancer risk factors and developing new treatments, interventions, and preventative measures in younger women. Below are five important things we know so far, along with the warning signs every young woman should be aware of.

Signs of Breast Cancer in Young Women

Because most women under 40 are not yet in routine screening programs, self-detection is often how younger women first identify a potential concern. Research suggests that nearly 80% of young women who are diagnosed with breast cancer find their own abnormality, which makes knowing what to look and feel for an important part of staying informed about your health.

Warning signs of breast cancer in young women include:

• A new or unusual lump in the breast or underarm area
• Persistent breast pain that is not related to the menstrual cycle
• Skin changes such as redness, dimpling, or puckering on the breast
• A newly inverted nipple
• Nipple discharge, with or without pain
• Swollen lymph nodes in the underarm or around the collarbone

It is worth noting that many breast lumps in younger women are benign. Common noncancerous causes include cysts and fibroadenomas. Even so, any breast change that persists or cannot be explained should be evaluated by a healthcare provider rather than monitored and dismissed.

A note on Inflammatory Breast Cancer (IBC): This subtype of cancer does not always produce a discrete lump. Instead, it tends to present with redness, warmth, and swelling of the breast, sometimes with a texture resembling an orange peel. Inflammatory breast cancer tends to occur at a younger age than most other breast cancers, and Black women are more likely to develop IBC than white women. Its distinct symptom profile means it can be overlooked if someone is only checking for lumps.

5 Facts About Breast Cancer in Younger Women

Staying alert to physical signs empowers younger women to advocate for their health, but understanding the disease’s unique realities is equally important. From tumor biology to long-term side effects, here are five key findings from current research:

1. Young women are more likely to have aggressive forms of the disease.

Breast cancers in women under 40 are more likely to have features that can contribute to poorer prognoses and outcomes: larger tumor size, advanced tumor stage, negative hormone receptor status, and an over-expression of the HER2 protein. Triple-negative breast cancer (TNBC), a particularly aggressive subtype without many targeted treatment options, though that is changing, is also more common in younger women. Hormone receptor (HR)-positive breast cancer, the most common breast cancer subtype overall and generally considered more treatable, is contributing to the rising incidence of breast cancer in younger women. Research has shown that HR-positive tumors diagnosed in younger women tend to have worse outcomes than the same subtype diagnosed in older women, independent of stage.

2. Racial disparities are pervasive among young Black women.

Black women are nearly twice as likely to be diagnosed with TNBC compared to white women aged 20 to 44. Also, studies show that Black women aged 20 to 39 are more likely to develop breast cancer of any subtype compared to younger women of other racial and ethnic groups, and one-and-a-half times more likely to develop breast cancer compared to white women between the ages of 20 and 29.

3. Younger patients are more likely to have genetic risk factors for breast cancer.

Inherited mutations in the BRCA1 or BRCA2 genes, which increase breast cancer risk, are more commonly seen in young women. While about 6% of all women with breast cancer are carriers for BRCA mutations, the number is closer to 12% in patients under 45 with breast cancer. Women of Ashkenazi Jewish descent are particularly vulnerable because BRCA mutations are more prevalent in this group.

A younger woman’s breast cancer risk is also higher if she:

• Had her first menstrual period before age 12.
• Had her first pregnancy over age 30 or has not had children. (Conversely, breastfeeding and pregnancy before age 30 offer protective benefits.)

And if one or more family members who:

• Has a family history of breast cancer (especially if a relative was diagnosed under 50, had bilateral breast cancer, or was male).
• Has a family history of ovarian, pancreatic, or metastatic prostate cancer.

4. Discussing breast symptoms and concerns can be more challenging for young women.

Advocating for your health is difficult at any age, but younger women often face distinct hurdles.

A young woman may not recognize her symptoms, and even if she does, she might feel ignored when expressing specific concerns with her doctor. And if she’s under 40, she may not receive a mammogram, as they aren’t recommended for this age group and were only recently recommended for all women between the ages of 40-49 by the influential U.S. Preventive Services Task Force. Even when mammograms are performed, younger women are more likely to have dense breast tissue, which can obscure tumors and delay diagnosis until the cancer is more advanced.

5. Cancer treatments pose unique challenges for younger patients.

Fertility is a major worry for young patients who want to start or grow their families. At diagnosis, approximately half of younger women said they were worried about treatment-induced infertility, but few pursue fertility-preservation strategies. While such measures can be effective, they can also worsen the financial, physical, and emotional stresses young women already experience from cancer treatment.

Lifesaving cancer treatments can impact patients’ quality of life at any age. For young women in particular, breast cancer treatments such as certain chemotherapies and hormone therapies can cause temporary or permanent menopause long before it would naturally occur. Menopause symptoms after treatment can seriously affect a younger woman’s sexual and mental health, along with her sleep quality. While menopause hormone therapy may help relieve some symptoms, it isn’t an option for many breast cancer survivors since it can increase recurrence risk. Researchers are actively investigating non-hormonal approaches to managing these symptoms offering hope for improved quality of life for survivors who cannot safely use menopause hormone therapy.

Research has shown that some chemotherapies and targeted treatments can have a toxic effect on patients’ hearts years, or even decades, after treatment. Younger women who live many years beyond breast cancer treatment can develop long-term heart health complications that require surveillance and treatment. 

What BCRF Research Means for Young Women Today

The five facts above, taken together, point to a reality that researchers and clinicians are working urgently to address: Incidence of breast cancer in younger women is rising, the disease tends to be more aggressive, and the effects of treatment can follow younger patients for decades. Understanding these realities is the first step toward changing them.

Over the last 30 years, BCRF-funded research has contributed significantly to what the scientific community now knows about breast cancer in younger women. That includes a deeper understanding of the genetic and biological factors that drive more aggressive subtypes, clearer evidence of the racial disparities that place young Black women at disproportionate risk, and growing insight into how to support younger patients through the long-term physical and emotional consequences of treatment.

The work is far from finished. The Foundation recently announced an investment to establish BCRFs Global Research Initiative on Breast Cancer in Younger Women. BCRF investigators continue to study why incidence is rising in this age group, how to improve early detection for women who fall outside standard screening guidelines, and how to develop treatments that are both effective and protective of quality of life. For younger women navigating a diagnosis today, and for those who simply want to understand their risk, that research matters. It is the foundation on which better outcomes are built.

Frequently Asked Questions